; Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of DUSA Pharmaceuticals, Inc. Shareholders
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of DUSA Pharmaceuticals, Inc. Shareholders

VIEWS: 10 PAGES: 2

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP is investigating potential claims against the Board of Directors of DUSA Pharmaceuticals, Inc. (“DUSA” or the “Company”) (NASDAQ: DUSA) related to the proposed acquisition of the Company by Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Sun Pharmaceutical will commence a tender offer to acquire all of the outstanding common stock of DUSA for $8.00 per share in cash, or approximately $230 million. The investigation concerns a style='font-size: 1

More Info
To top
;